For years, clues pointed to the gut microbiome as a key factor in cancer treatment outcomes. Recent advances in gene sequencing are now clarifying its influence on how patients respond to therapy. At City of Hope, this clarity has catalyzed a more comprehensive model for microbiome science in cancer care. We define the microbiome as the last discovered organ—one that can be characterized and monitored clinically and integrated into a framework t…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.